This inventor holds 2 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2005
Title: Kenneth J Weese: Innovator in Serine Protease Inhibitors
Introduction
Kenneth J Weese is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of 2 patents, his work has implications for treating clotting disorders.
Latest Patents
Kenneth's latest patents focus on compounds that inhibit serine protease enzymes, such as TF/factor VIIa, factor Xa, thrombin, and kallikrein. These compounds are designed to be useful in methods of preventing and/or treating clotting disorders. The specific structures of these compounds are defined in his patents, showcasing their potential therapeutic applications.
Career Highlights
Kenneth J Weese is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to explore and develop groundbreaking solutions in the field of protease inhibition.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Ignacio Aliagas-Martin and Dean R Artis. These collaborations have further enriched his research and contributed to the advancement of his inventions.
Conclusion
Kenneth J Weese's contributions to the field of serine protease inhibitors highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the landscape of biochemistry and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile